These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 2931286)

  • 1. Mechanisms involved in the vasodilator action of 5-hydroxytryptamine in the dog femoral arterial circulation in vivo.
    Phillips CA; Mylecharane EJ; Shaw J
    Eur J Pharmacol; 1985 Jul; 113(3):325-34. PubMed ID: 2931286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for a central component to the hypotensive action of ketanserin in the dog.
    Mylecharane EJ; Phillips CA; Markus JK; Shaw J
    J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S114-6. PubMed ID: 2412028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potentiation of responses to sympathetic nerve stimulation and vasoconstrictor agents by SK&F 103829 in the feline mesenteric circulation.
    Taylor EM; Kaumann AJ
    Br J Pharmacol; 1994 Jan; 111(1):264-70. PubMed ID: 8012704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypotensive actions of ketanserin in dogs: involvement of a centrally mediated inhibition of sympathetic vascular tone.
    Phillips CA; Mylecharane EJ; Markus JK; Shaw J
    Eur J Pharmacol; 1985 May; 111(3):319-27. PubMed ID: 2862048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mediation of 5-HT-induced external carotid vasodilatation in GR 127935-pretreated vagosympathectomized dogs by the putative 5-HT7 receptor.
    Villalón CM; Centurión D; Luján-Estrada M; Terrón JA; Sánchez-López A
    Br J Pharmacol; 1997 Apr; 120(7):1319-27. PubMed ID: 9105708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modification of the vasomotor actions of methysergide in the femoral arterial bed of the anaesthetized dog by changes in sympathetic nerve activity.
    Feniuk W; Humphrey PP; Watts AD
    J Auton Pharmacol; 1981 Mar; 1(2):127-32. PubMed ID: 6121808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pizotifen, an antimigraine drug with venoconstrictor activity in vivo.
    Müller-Schweinitzer E
    J Cardiovasc Pharmacol; 1986; 8(4):805-10. PubMed ID: 2427822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of serotonin-induced increase in canine external carotid blood flow by drugs that decrease the sympathetic outflow.
    Terrón JA; Hong E; López-Muñoz FJ; Villalón CM
    J Auton Pharmacol; 1994 Jun; 14(3):165-75. PubMed ID: 7929471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vasodilator and vasoconstrictor responses induced by 5-hydroxytryptamine in the in situ blood autoperfused hindquarters of the anaesthetized rat.
    Calama E; Fernández MM; Morán A; Martín ML; San Román L
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Aug; 366(2):110-6. PubMed ID: 12122496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular dopamine receptors in the canine hindlimb.
    Bell C; Conway EL; Lang WJ; Padanyi R
    Br J Pharmacol; 1975 Oct; 55(2):167-72. PubMed ID: 1201374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of action of OPC-28326, a selective hindlimb vasodilator.
    Orito K; Imaizumi T; Yoshida K; Fujiki H; Kishi M; Teramoto S; Tanaka M; Shimizu H; Tominaga M; Kimura Y; Kambayashi J; Mori T
    J Pharmacol Exp Ther; 1999 Nov; 291(2):604-11. PubMed ID: 10525078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of 5-HT1-like receptors in the increase in external carotid blood flow induced by 5-hydroxytryptamine in the dog.
    Villalón CM; Terrón JA; Hong E
    Eur J Pharmacol; 1993 Aug; 240(1):9-20. PubMed ID: 8405128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of responses to serotonin in the pulmonary vascular bed of the cat.
    McMahon TJ; Hood JS; Nossaman BD; Kadowitz PJ
    J Appl Physiol (1985); 1993 Jul; 75(1):93-102. PubMed ID: 8104177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antihypertensive properties of ketanserin (R 41 468).
    Vanhoutte PM; Van Nueten JM; Symoens J; Janssen PA
    Fed Proc; 1983 Feb; 42(2):182-5. PubMed ID: 6295821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Excitatory and inhibitory effects of 5-hydroxytryptamine in mesenteric arteries of spontaneously hypertensive rats.
    Su C; Uruno T
    Eur J Pharmacol; 1984 Nov; 106(2):283-90. PubMed ID: 6529977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serotonin-induced vasoconstriction in the perfused canine femoral artery can be blocked in vivo by ketanserin.
    Meschig R; Breuer J; Arnold G
    J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S56-9. PubMed ID: 2412060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can peripheral serotonergic blockade explain the hypotensive effect of ketanserin?
    Vanhoutte PM
    J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S105-9. PubMed ID: 2412025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5-Carboxamidotryptamine is a selective agonist at 5-hydroxytryptamine receptors mediating vasodilatation and tachycardia in anaesthetized cats.
    Connor HE; Feniuk W; Humphrey PP; Perren MJ
    Br J Pharmacol; 1986 Feb; 87(2):417-26. PubMed ID: 2937503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction between 5-hydroxytryptamine and other vasoconstrictor substances in the isolated femoral artery of the rabbit; effect of ketanserin (R 41 468).
    Van Nueten JM; Janssen PA; De Ridder A; Vanhoutte PM
    Eur J Pharmacol; 1982 Feb; 77(4):281-7. PubMed ID: 7060640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Presynaptic inhibition of vascular sympathetic neurotransmission by adenosine.
    Hom GJ; Lokhandwala MF
    Eur J Pharmacol; 1981 Jan; 69(1):101-6. PubMed ID: 6258939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.